6.77
+0.015(+0.22%)
Currency In USD
| Previous Close | 6.75 |
| Open | 6.73 |
| Day High | 6.87 |
| Day Low | 6.67 |
| 52-Week High | 10.79 |
| 52-Week Low | 4.54 |
| Volume | 290,635 |
| Average Volume | 455,812 |
| Market Cap | 425.55M |
| PE | -7.96 |
| EPS | -0.85 |
| Moving Average 50 Days | 7.52 |
| Moving Average 200 Days | 7.27 |
| Change | 0.02 |
If you invested $1000 in Treace Medical Concepts, Inc. (TMCI) since IPO date, it would be worth $264.98 as of May 16, 2025 at a share price of $6.765. Whereas If you bought $1000 worth of Treace Medical Concepts, Inc. (TMCI) shares 3 years ago, it would be worth $458.02 as of May 16, 2025 at a share price of $6.765.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Treace to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 24, 2025 8:05 PM GMT
PONTE VEDRA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defo
Treace Announces Upcoming Board Chair Transition
GlobeNewswire Inc.
Apr 07, 2025 12:00 PM GMT
PONTE VEDRA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defo
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
GlobeNewswire Inc.
Mar 28, 2025 6:00 PM GMT
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defo